ASL
Basic information
Region (hg38): 7:66075800-66094697
Links
Phenotypes
GenCC
Source:
- argininosuccinic aciduria (Definitive), mode of inheritance: AR
- argininosuccinic aciduria (Definitive), mode of inheritance: AR
- argininosuccinic aciduria (Strong), mode of inheritance: AR
- argininosuccinic aciduria (Definitive), mode of inheritance: AR
- argininosuccinic aciduria (Supportive), mode of inheritance: AR
- argininosuccinic aciduria (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Argininosuccinic aciduria | AR | Biochemical; Pharmacogenomic | Dietary and medical therapy (eg, with low-protein diet supplemented with arginine), may be beneficial, and special care to prevent/treat acute metabolic decompensation (eg, with IV glucose and ammonia-reducing agents) may be effective; Certain agents (such as enflurane, an anesthetic agent) should be avoided due to reports of adverse reactions | Biochemical; Dermatologic; Neurologic | 13503250; 5836520; 84150; 2263616; 1897577; 1594374; 9504797; 12408190; 12384776; 17326097; 22541557; 20236848; 19635676; 22541557; 22841516; 23040521; 25135652 |
ClinVar
This is a list of variants' phenotypes submitted to
- Argininosuccinate_lyase_deficiency (821 variants)
- not_provided (94 variants)
- not_specified (60 variants)
- Inborn_genetic_diseases (36 variants)
- ASL-related_disorder (12 variants)
- Neurodevelopmental_disorder (3 variants)
- Autism (1 variants)
- Congenital_myasthenic_syndrome_4C (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ASL gene is commonly pathogenic or not. These statistics are base on transcript: NM_000000048.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 12 | 234 | 248 | |||
| missense | 16 | 113 | 114 | 253 | ||
| nonsense | 16 | 16 | 33 | |||
| start loss | 1 | 1 | ||||
| frameshift | 22 | 28 | 50 | |||
| splice donor/acceptor (+/-2bp) | 15 | 28 | 45 | |||
| Total | 69 | 186 | 128 | 244 | 3 |
Highest pathogenic variant AF is 0.0018317379
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| ASL | protein_coding | protein_coding | ENST00000304874 | 16 | 17761 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 8.57e-10 | 0.899 | 125678 | 0 | 66 | 125744 | 0.000262 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.749 | 247 | 282 | 0.875 | 0.0000195 | 3011 |
| Missense in Polyphen | 78 | 107.79 | 0.72365 | 1152 | ||
| Synonymous | -1.37 | 134 | 115 | 1.16 | 0.00000822 | 908 |
| Loss of Function | 1.83 | 19 | 29.8 | 0.638 | 0.00000168 | 303 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000150 | 0.000150 |
| Ashkenazi Jewish | 0.000199 | 0.000198 |
| East Asian | 0.000383 | 0.000381 |
| Finnish | 0.000200 | 0.000185 |
| European (Non-Finnish) | 0.000360 | 0.000352 |
| Middle Eastern | 0.000383 | 0.000381 |
| South Asian | 0.000263 | 0.000261 |
| Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Disease
- DISEASE: Argininosuccinic aciduria (ARGINSA) [MIM:207900]: An autosomal recessive disorder of the urea cycle. The disease is characterized by mental and physical retardation, liver enlargement, skin lesions, dry and brittle hair showing trichorrhexis nodosa microscopically and fluorescing red, convulsions, and episodic unconsciousness. {ECO:0000269|PubMed:12408190, ECO:0000269|PubMed:1705937, ECO:0000269|PubMed:17326097, ECO:0000269|PubMed:19703900, ECO:0000269|PubMed:2263616, ECO:0000269|PubMed:24166829}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Alanine, aspartate and glutamate metabolism - Homo sapiens (human);Arginine biosynthesis - Homo sapiens (human);Argininemia;Hyperornithinemia with gyrate atrophy (HOGA);Creatine deficiency, guanidinoacetate methyltransferase deficiency;L-arginine:glycine amidinotransferase deficiency;Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome];Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency);Citrullinemia Type I;Carbamoyl Phosphate Synthetase Deficiency;Argininosuccinic Aciduria;Hypoacetylaspartia;Urea Cycle;Aspartate Metabolism;Prolinemia Type II;Prolidase Deficiency (PD);Ornithine Transcarbamylase Deficiency (OTC Deficiency);Arginine and Proline Metabolism;Hyperprolinemia Type I;Hyperprolinemia Type II;Ornithine Aminotransferase Deficiency (OAT Deficiency);Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency);Canavan Disease;Alanine and aspartate metabolism;Urea cycle and metabolism of amino groups;Citrate cycle;Alanine Aspartate Asparagine metabolism;Metabolism of polyamines;Metabolism of amino acids and derivatives;Metabolism;citrulline-nitric oxide cycle;urea cycle;Arginine Proline metabolism;Urea cycle
(Consensus)
Recessive Scores
- pRec
- 0.454
Intolerance Scores
- loftool
- 0.0497
- rvis_EVS
- -0.98
- rvis_percentile_EVS
- 8.85
Haploinsufficiency Scores
- pHI
- 0.0865
- hipred
- N
- hipred_score
- 0.112
- ghis
- 0.460
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.964
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Asl
- Phenotype
- endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); muscle phenotype; renal/urinary system phenotype; immune system phenotype; homeostasis/metabolism phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype;
Gene ontology
- Biological process
- urea cycle;locomotory behavior;post-embryonic development;ammonia assimilation cycle;arginine biosynthetic process via ornithine
- Cellular component
- cytoplasm;cytosol;extracellular exosome
- Molecular function
- argininosuccinate lyase activity;protein binding;identical protein binding